These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7264507)

  • 1. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
    Wald RW; Waxman MB; Colman JM
    J Electrocardiol; 1981 Jul; 14(3):301-7. PubMed ID: 7264507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
    Keren A; Tzivoni D; Gottlieb S; Benhorin J; Stern S
    Chest; 1982 Mar; 81(3):384-6. PubMed ID: 7056119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide.
    Commerford PJ; Beck W
    S Afr Med J; 1980 Sep; 58(11):447-8. PubMed ID: 7404173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disopyramide-induced Torsade de Pointes.
    Tzivoni D; Keren A; Stern S; Gottlieb S
    Arch Intern Med; 1981 Jun; 141(7):946-7. PubMed ID: 7235820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
    Dhurandhar RW; Nademanee K; Goldman AM
    Heart Lung; 1978; 7(5):783-7. PubMed ID: 250503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs.
    Croft CH; Kennelly BM
    S Afr Med J; 1981 Jun; 59(24):871-3. PubMed ID: 7233313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular pacing in atypical ventricular tachycardia.
    Keren A; Tzivoni D; Golhman JM; Corcos P; Benhorin J; Stern S
    J Electrocardiol; 1981; 14(2):201-5. PubMed ID: 7276791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
    Meltzer RS; Robert EW; McMorrow M; Martin RP
    Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disopyramide induced atypical ventricular tachycardia.
    Chia BL
    Aust N Z J Med; 1980 Dec; 10(6):665-8. PubMed ID: 6938189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
    JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atypical ventricular tachycardia due to disopyramide].
    Feigl D; Ashkenazi J; Schwarzmann H
    Harefuah; 1982 Mar; 102(6):246-7. PubMed ID: 7160719
    [No Abstract]   [Full Text] [Related]  

  • 13. Disopyramide-induced ventricular fibrillation.
    Nicholson WJ; Martin CE; Gracey JG; Knoch HR
    Am J Cardiol; 1979 May; 43(5):1053-5. PubMed ID: 433766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Three cases of torsades de pointes due to anti-arrhythmic agents].
    Yasuda M; Toda I; Akioka K; Teragaki M; Oku H; Takeuchi K; Takeda T; Inoue E; Ikuno Y; Horiguchi T
    Nihon Naika Gakkai Zasshi; 1986 Sep; 75(9):1262-6. PubMed ID: 3794468
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.
    Roden DM; Woosley RL; Primm RK
    Am Heart J; 1986 Jun; 111(6):1088-93. PubMed ID: 3716982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disopyramide-induced ventricular tachycardia.
    Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
    Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
    Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
    Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial activation patterns of torsade de pointes in canine hearts with quinidine-induced long QT interval but without myocardial infarction.
    Inoue H; Murakawa Y; Toda I; Nozaki A; Matsuo H; Mashima S; Sugimoto T
    Am Heart J; 1986 Jun; 111(6):1080-7. PubMed ID: 3716981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disopyramide-induced QT prolongation and ventricular tachyarrhythmias.
    Riccioni N; Castiglioni M; Bartolomei C
    Am Heart J; 1983 May; 105(5):870-1. PubMed ID: 6846134
    [No Abstract]   [Full Text] [Related]  

  • 20. [Paradoxic response to disopyramide and quinidine (author's transl)].
    Breithardt G; Seipel L; Haerten K
    Z Kardiol; 1980 Aug; 69(8):556-61. PubMed ID: 7445656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.